Accessibility: Skip TopNav
Mark Shearman
Editas Medicine announced that it named Mark Shearman as the Company's Executive Vice President and Chief Scientific Officer.
Format
JPEG
Source
Editas Medicine, Inc.
Downloads
Original
Large
Medium
Small